Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Faculty Opinions recommendation of Current and future pharmacological therapies for NAFLD/NASH. — Ralf Weiskirchen | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Faculty Opinions recommendation of Current and future pharmacological therapies for NAFLD/NASH.
RW
Shared by
Ralf Weiskirchen
Faculty Opinions recommendation of Current and future pharmacological therapies for NAFLD/NASH.
Dataset
en
Authors
RW
Ralf Weiskirchen
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Dataset
Faculty Opinions recommendation of Liver Disease in Alpha-1 Antitrypsin Deficiency: Current Approaches and Future Directions.
Ralf Weiskirchen
Dataset
Faculty Opinions recommendation of The role of myeloid cells in cancer therapies.
Alberto Mantovani
DOI
10.3410/f.732323132.793547490
Year
Published
—
Language
en
Dataset Details
Link Of The Paper
https://doi.org/10.3410/f.732323132.793547490
Timeline
Created:
June 19, 2026
Dataset
Faculty Opinions recommendation of Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease.
Ralf Weiskirchen
Article
2019
Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
Hannah K. Drescher
,
Sabine Weiskirchen
,
Ralf Weiskirchen
Dataset
Faculty Opinions recommendation of Projected effect of dietary salt reductions on future cardiovascular disease.
Giuseppe Remuzzi
,
Arrigo Schieppati
Discussion(0)
No comments yet. Be the first to comment.